GGrantIndex
← Leaderboards

Robert C Kaplan

Albert Einstein Col Of Med Yeshiva Univ

$30,160,514
Attributed
$60,508,948
Total exposure
17
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $10.6M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$60,508,948 · 17

By mechanism

R01$42,065,432 · 13
U24$16,636,716 · 1
N01$1,000,000 · 1
U01$446,507 · 1
R21$360,293 · 1

Others in their field

Top investigators on “Cohort

Research focus

CohortRisk FactorsParticipantCohort StudiesCardiovascular DiseasesLinkInflammationWomanAdultMeasurementEventInsightProspectiveCardiovascular SystemPharmaceutical PreparationsAtherosclerosisMetabolicBaseUltrasonographyAffectLipidsCardiovascular Disorder RiskDiabetes MellitusCarotid Arteries

Grant awards (63)

Hawaiian, Asian American, and Pacific Islander (HAAPI) Coordinating Center$8,753,539
U24 · FY2025 · HL
Microbiome and AD/ADRD Risk in SOL$856,580
R01 · FY2025 · AG
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults$695,447
R01 · FY2025 · DK · contact PI
MOSAAIC Cognitive Assessment Reading Center Administrative Supplement$299,670
U24 · FY2025 · HL
Hawaiian, Asian American, and Pacific Islander (HAAPI) Coordinating Center$4,168,697
U24 · FY2024 · HL
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults$645,272
R01 · FY2024 · DK · contact PI
Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) Administrative Supplement for PBMCs and RNA PaxGene$441,897
U24 · FY2024 · HL
Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) Administrative Supplement$372,945
U24 · FY2024 · HL
Hawaiian, Asian American, and Pacific Islander (HAAPI) Coordinating Center$2,599,968
U24 · FY2023 · HL
HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)$1,000,000
N01 · FY2023 · HL · contact PI
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults$772,730
R01 · FY2023 · DK · contact PI
PASOS: Peripheral Artery Disease Study of SOL. An ancillary study of the Hispanic Community Health Study/Study of Latinos$1,905,674
R01 · FY2022 · HL · contact PI
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV$819,924
R01 · FY2022 · HL · contact PI
Sex differences in the role of multi-omics in HIV-associated carotid artery atherosclerosis$446,507
U01 · FY2022 · HL
PASOS: Peripheral Artery Disease Study of SOL. An ancillary study of the Hispanic Community Health Study/Study of Latinos$2,156,809
R01 · FY2021 · HL · contact PI
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV$814,084
R01 · FY2021 · HL · contact PI
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites$777,067
R01 · FY2021 · HL
PASOS: Peripheral Artery Disease Study of SOL. An ancillary study of the Hispanic Community Health Study/Study of Latinos$2,175,987
R01 · FY2020 · HL · contact PI
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV$843,391
R01 · FY2020 · HL · contact PI
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites$790,750
R01 · FY2020 · HL
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$752,099
R01 · FY2020 · MD · contact PI
Cardiometabolic Outcomes in Multi-ethnic Physical Activity & Sedentary Behavior Study (COMPASS)$743,025
R01 · FY2020 · HL
PASOS: Peripheral Artery Disease Study of SOL. An ancillary study of the Hispanic Community Health Study/Study of Latinos$2,182,970
R01 · FY2019 · HL · contact PI
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV$846,562
R01 · FY2019 · HL · contact PI
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites$811,490
R01 · FY2019 · HL
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$762,057
R01 · FY2019 · MD · contact PI
Evaluation of HIV-associated Cardiac Dysfunction in Women$706,647
R01 · FY2019 · HL
Cardiometabolic Outcomes in Multi-ethnic Physical Activity & Sedentary Behavior Study (COMPASS)$596,085
R01 · FY2019 · HL
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$439,524
R01 · FY2019 · MD · contact PI
Cardiometabolic Outcomes in Multi-ethnic Physical Activity & Sedentary Behavior Study (COMPASS)$158,292
R01 · FY2019 · HL
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites$876,359
R01 · FY2018 · HL
Evaluation of HIV-associated Cardiac Dysfunction in Women$812,548
R01 · FY2018 · HL
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$768,196
R01 · FY2018 · MD · contact PI
Cardiometabolic Outcomes in Multi-ethnic Physical Activity & Sedentary Behavior Study (COMPASS)$744,689
R01 · FY2018 · HL
Cardiometabolic Outcomes in Multi-ethnic Physical Activity & Sedentary Behavior Study (COMPASS)$864,455
R01 · FY2017 · HL
Evaluation of HIV-associated Cardiac Dysfunction in Women$817,073
R01 · FY2017 · HL
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$764,306
R01 · FY2017 · MD · contact PI
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms$503,014
R01 · FY2017 · HL · contact PI
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms$309,610
R01 · FY2017 · HL · contact PI
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms$308,838
R01 · FY2017 · HL · contact PI
Evaluation of HIV-associated Cardiac Dysfunction in Women$848,351
R01 · FY2016 · HL
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms$841,929
R01 · FY2016 · HL · contact PI
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$829,412
R01 · FY2016 · MD · contact PI
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms$643,683
R01 · FY2015 · HL · contact PI
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms$214,561
R01 · FY2015 · HL · contact PI
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms$919,962
R01 · FY2014 · HL · contact PI
CVD and inflammation across the lifespan in HIV infected adults and children$157,526
R21 · FY2014 · HL
CVD and inflammation across the lifespan in HIV infected adults and children$202,767
R21 · FY2013 · HL
Epidemiology of IGF's and Aging$471,283
R01 · FY2012 · AG · contact PI
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women$423,448
R01 · FY2012 · HL · contact PI
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women$836,571
R01 · FY2011 · HL · contact PI
Epidemiology of IGF's and Aging$589,865
R01 · FY2011 · AG · contact PI
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women$829,735
R01 · FY2010 · HL · contact PI
Epidemiology of IGF's and Aging$596,351
R01 · FY2010 · AG · contact PI
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women$838,967
R01 · FY2009 · HL · contact PI
Mechanisms of Atherosclerosis and CVD in HIV+ Women$668,811
R01 · FY2009 · HL · contact PI
Epidemiology of IGF's and Aging$623,702
R01 · FY2009 · AG · contact PI
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women$864,994
R01 · FY2008 · HL · contact PI
Mechanisms of Atherosclerosis and CVD in HIV+ Women$574,885
R01 · FY2008 · HL · contact PI
Mechanisms of Atherosclerosis and CVD in HIV+ Women$579,110
R01 · FY2007 · HL · contact PI
Mechanisms of Atherosclerosis and CVD in HIV+ Women$633,315
R01 · FY2006 · HL · contact PI
Epidemiology of IGF and Cardiovascular Events$593,914
R01 · FY2005 · HL
Epidemiology of IGF and Cardiovascular Events$621,029
R01 · FY2004 · HL